Technology · Application Software

Dolby Laboratories DLB

$52.51+1.24 (+2.42%)delayed quote · as of 2026-07-29 06:58 UTC

Open DLB in the workspaceCharts, statements, and the evidence behind every figure — free to start.

Market cap

$5.0B

Previous close

$51.27

Volume

680K

52-week range

$48.26 – $76.70

Verdictconfidence 100% · high

Attractively priced, with the trend still against it.

4 of 5 dimensions score well; momentum flashes caution.

Value1004/4 checks

Growth1004/4 checks

Quality672/3 checks

Health1003/3 checks

Momentum00/5 checks

Fair-value estimate $157.13 per share (2-stage FCF · sector beta · 10Y Rf 4.7%) — the price sits 67% below it.

Every check behind these scores — with its numbers, source, and evidence link — is in the workspace. Free account required.

Key ratioslatest filing FY 2025

Value

P/E TTM

20.8

P/E FWD

11.4

EV/EBITDA TTM

11.9

PEG

0.60

Growth

Revenue 3y

+2.5%/yr

Revenue YoY

+5.9%

Expected EPS

+82.0%

Quality

ROE

9.7%

Quality checks

bank measures

Health

Equity/assets

81.3%

Solvency score

n/a for financials

Momentum

vs 50-day

−16.7%

vs 200-day

−22.7%

52-wk range

15%

FY 2025: revenue $1.3B · net income $255.0M · free cash flow $435.9M (SEC EDGAR filings)

ALAN GLOBAL INTELLIGENCE · alanglobalintelligence.comquote as of 2026-07-29 06:58 UTC · fundamentals FY 2025 · SEC EDGAR

Verdict

Reading DLB’s filed statements…

Continue with DLB in ALAN

Full evidence trail, financial statements back a decade, valuation history, charts, and alerts.

Open in the workspace Create free account

For information and research only. Not investment advice. ALAN does not place trades or execute orders. Figures come from the sources shown and can lag the market; verify independently before making decisions. Past performance is not predictive of future results.